BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6514723)

  • 1. Thrombospondin plays a role in platelet-platelet recognition during release-related aggregation.
    Agam G; Shohat O; Livne A
    Proc Soc Exp Biol Med; 1984 Dec; 177(3):482-6. PubMed ID: 6514723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-platelet recognition during aggregation: distinct mechanisms determined by the release reaction.
    Agam G; Livne A
    Thromb Haemost; 1984 Apr; 51(2):145-9. PubMed ID: 6740546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin promotes platelet aggregation.
    Tuszynski GP; Rothman VL; Murphy A; Siegler K; Knudsen KA
    Blood; 1988 Jul; 72(1):109-15. PubMed ID: 3390605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution and reconstitution of interplatelet recognition during aggregation.
    Agam G; Livne A
    Thromb Haemost; 1988 Jun; 59(3):504-6. PubMed ID: 3187935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen fragment D is a recognition site for release-related platelet aggregation.
    Agam G; Shohat O; Livne A
    Thromb Res; 1985 Mar; 37(6):629-38. PubMed ID: 3992532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thrombospondin in platelet aggregation.
    Leung LL
    J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
    Kao KJ; Shaut DM; Klein PA
    Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin: a versatile multifunctional glycoprotein.
    Silverstein RL; Leung LL; Nachman RL
    Arteriosclerosis; 1986; 6(3):245-53. PubMed ID: 3518684
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies against a 23Kd heparin binding fragment of thrombospondin inhibit platelet aggregation.
    Gartner TK; Walz DA; Aiken M; Starr-Spires L; Ogilvie ML
    Biochem Biophys Res Commun; 1984 Oct; 124(1):290-5. PubMed ID: 6497883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive participation of fixed platelets in aggregation facilitated by covalently bound fibrinogen.
    Agam G; Livne A
    Blood; 1983 Jan; 61(1):186-91. PubMed ID: 6848143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the platelet agglutinating activity of thrombospondin.
    Haverstick DM; Dixit VM; Grant GA; Frazier WA; Santoro SA
    Biochemistry; 1985 Jun; 24(13):3128-34. PubMed ID: 4027236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-thrombospondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin.
    Dixit VM; Haverstick DM; O'Rourke KM; Hennessy SW; Grant GA; Santoro SA; Frazier WA
    Biochemistry; 1985 Jul; 24(16):4270-5. PubMed ID: 4052397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
    Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
    Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist.
    Savi P; Bernat A; Lalé A; Roque C; Zamboni G; Herbert JM
    Platelets; 2000 Feb; 11(1):43-8. PubMed ID: 10938881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
    Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
    Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of fibrinogen with platelets. Review].
    Regañón E; Aznar J; Vila V
    Sangre (Barc); 1985; 30(4-A):449-57. PubMed ID: 3000005
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoproteins IIb and IIIa and platelet thrombospondin in a liposome model of platelet aggregation.
    Rybak ME
    Thromb Haemost; 1986 Apr; 55(2):240-5. PubMed ID: 2940724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin as an agglutinin of platelets.
    Satoh S; Takahashi K; Sakuragawa N
    Thromb Res; 1993 Dec; 72(6):509-17. PubMed ID: 8128455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.